Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2006
09/13/2006EP1203086B1 Mites-like element and transcriptional activation element
09/13/2006EP1196579B1 Tryptase inhibitor
09/13/2006EP1196431B1 A substantially crystalline form of melagatran
09/13/2006EP1163272B1 Antibodies specific for cyp1b1
09/13/2006EP1140158B1 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
09/13/2006EP1094835B1 Process for manufacturing of a pharmaceutical composition comprising human apotransferrin
09/13/2006EP1088084B1 Erythropoietin analog-human serum albumin fusion protein
09/13/2006EP1064025B1 Combined vaccine compositions
09/13/2006EP1002134B1 Detection of wheat fungal pathogens using the polymerase chain reaction
09/13/2006EP0981545B1 IGFIIE/ IGFBP2 complex
09/13/2006EP0832093B1 Expression of lipoproteins
09/13/2006EP0811065B1 Antagonists of interleukin-15
09/13/2006EP0773296B1 Secretory signal gene and expression vector having the same
09/13/2006EP0755446B1 Cardiotrophin and uses therefor
09/13/2006CN1833027A Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
09/13/2006CN1833024A Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto
09/13/2006CN1833022A Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequence and their therapeutic use
09/13/2006CN1832964A Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46
09/13/2006CN1832963A Specific inhibition of allograft rejection
09/13/2006CN1832962A Preparation of somatostatin peptides
09/13/2006CN1832961A Fungus resistant plants and their uses
09/13/2006CN1832960A Immunomodulating compositions, uses therefor and processes for their production
09/13/2006CN1832959A Polyethelene glycol link glp-1 compounds
09/13/2006CN1832956A Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
09/13/2006CN1832756A Method of altering the binding specificity of proteins by oxidation-reduction reactions
09/13/2006CN1832753A Ghrelin analogs
09/13/2006CN1831127A Key gene for controlling chlorophyll metabolism and method for establishing plant green residence character therewith
09/13/2006CN1831124A Method for preparing fusion protein contg. human interferon-alpha 2 and human seralbumin and its products
09/13/2006CN1831123A Method for preparing fusion protein contg. human interferon-beta and human seralbumin and its products
09/13/2006CN1831011A Antigen epitope of beta2-microglobulin and its application
09/13/2006CN1831010A Regulatory factor for anti-reverse transcription of corn, and its coding gene and application thereof
09/13/2006CN1831009A Prawn white-spots syndrom virus (WSSV) membrane protein and its antibody
09/13/2006CN1831008A Rice blast fungus non-toxin gene Avr-pii and its application
09/13/2006CN1275041C Prognostic indicator
09/13/2006CN1274834C Man's serum albumin with man's parathormone (1-34) fusion protein and its application
09/13/2006CN1274830C Salmon calcitonin analogues and expression method for the same in vegetable oils
09/13/2006CN1274829C Anti EB virus resulted tumour polypeptide, and its use and preparing method
09/13/2006CN1274828C Mouse derived EPOR outer cell region and human NOK intracell region infused acceptor and coding gene and uses
09/13/2006CN1274827C Cancer gene and its coded protein and special cell line
09/13/2006CN1274823C Production of human interleukin 288 and recombined IL-288 engineering bacteria
09/13/2006CN1274821C Modular transport systems for molecular substances and production and use thereof
09/13/2006CN1274716C Method for extracting albumin transferrin with iron supplemented and antibacterial function
09/13/2006CN1274362C Medicine for preventing and treating AIDS
09/12/2006USRE39282 determining the sensitivity of samples containing human immunodeficiency virus to zidovudine by isolating nucleotides from cells of the patients, then amplifying, sequencing and analyzing for replacements relative to the wild type sequences
09/12/2006US7105725 Pathogen resistant transgenic plants expressing CEMA or CEMA-related peptides
09/12/2006US7105724 Methods and materials for making and using transgenic dicamba-degrading organisms
09/12/2006US7105723 Sugar and lipid metabolism regulators in plants
09/12/2006US7105720 Cloning; gene expression; isolation nucleotide sequence
09/12/2006US7105719 Gene encoding a protein having acyl group transfer activity
09/12/2006US7105717 Introduced with an SV 40 large T antigen gene under the control of probasin gene promoter; particularly related to the PBSVT transgenic rat 2971 lines; screening for a substance promoting the onset and/or progress of, or suppressing the onset and/or progress of prostate cancer
09/12/2006US7105656 Compositions and methods for treating hematologic malignancies and multiple drug resistance
09/12/2006US7105655 Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain
09/12/2006US7105653 Polypeptide comprising human interleukin-2 mutein with amino acid substitutions; , activates T cells over Natural Killer Cells; reduced toxicity; vectors, transformed host cells
09/12/2006US7105652 Human tumor suppressor gene
09/12/2006US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic
09/12/2006US7105650 Nucleotide sequences which code binding protein for use in taste simulation and food processing
09/12/2006US7105649 Gene and amplification with polynucleotides having amino acid sequence
09/12/2006US7105648 Oligomers substituted by phosphite acid ester, phosphonic acid or carbaborane functions and the corresponding PNA monomers
09/12/2006US7105647 cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use
09/12/2006US7105644 Secreted protein HHTLF25 antibodies
09/12/2006US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
09/12/2006US7105638 A fusion polypeptide with a cysteine-free hinge region and secondary structure that exposes the cleavage site to a selected endopeptidase
09/12/2006US7105636 SARA proteins
09/12/2006US7105635 Cyclic beta-sheet peptides useful as apoptotic/cytotoxic cancer agents
09/12/2006US7105485 HO-1 suppressor as a diagnostic and prognostic test for dementing diseases
09/12/2006US7105484 GDNF receptorα
09/12/2006US7105482 Administering {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; parasitic infections, thymoma, and lymphoid malignancies; prevents the metabolic degradation of the angiogenesis inhibitor
09/12/2006US7105481 Method for stimulating connective tissue growth or wound healing
09/12/2006US7105480 Administering a leptin or derivative, homologue, analogue, chemical equivalent or agonist to inhibit, reduce or delay onset or progression of bone resorption; treatiing osteoporosis and Paget's disease
09/12/2006US7105346 Packaging systems for human recombinant adenovirus to be used in gene therapy
09/12/2006US7105345 Useful for gene delivery
09/12/2006US7105344 Fluorescent proteins as cell-type specific reporters
09/12/2006US7105342 In vitro proliferation of pluripotent neural stem cell; obtain mammalian neural tissues, dissociate neural tissue into suspension, culture, passaging neural stem cell progeny to a second culture and propagate cells
09/12/2006US7105335 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
09/12/2006US7105332 Isolated pesticidal polypeptide from strains of Bacillus thuringiensis encoding delta -endotoxins having pesticidal activity against insect pests
09/12/2006US7105323 Residues of glutamic acid and aspartic acid in a channel of apoferritin complex are substituted with small polar amino acid residues, serine, or basic amino acid residues, lysine; preventing a repulsive electrostatic interaction
09/12/2006US7105321 Nucleotide sequences which code for the ccpA2 gene
09/12/2006US7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts
09/12/2006US7105316 Neisseria lactoferrin binding protein
09/12/2006US7105315 A cDNA encoding the protein, and an antibody that specifically binds the protein and their use to diagnose, to stage, to treat, or to monitor the progression or treatment of neoplastic disorders
09/12/2006US7105314 Natural insulin B chain lacking the B30 amino acid residue and a natural insulin A chain, a peptide sequence of one Pro not longer than 10 amino acid residues in length; connecting peptide with a cleavage site at its C-terminal
09/12/2006US7105309 Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
09/12/2006US7105307 Compositions and methods for screening for modulators of enzymatic activity
09/12/2006US7105306 Contacting cyclophilin B with a somatolactogenic hormone; decrease in binding of cyclophilin B to the somatolactogenic hormone indicates that the test compound decreases somatolactogenic hormone-induced cell proliferation
09/12/2006US7105305 Human platelet-derived growth factor receptors
09/12/2006US7105303 Antibodies to hepatitis C virus asialoglycoproteins
09/12/2006US7105297 Evolution of biocatalytic activity in cell; obtain nucleotide sequences, recombine sequences in gene, transform into cell, monitor cell for novel biocatalytic activity
09/12/2006US7105291 Detecting sensitivity to kidney disease
09/12/2006US7105290 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors
09/12/2006US7105171 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
09/12/2006US7105169 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
09/12/2006US7105168 PlGF results in functional improvement of a skeletal muscle in a mammal after a skeletal muscle ischemic event
09/12/2006US7105167 Administering variants of insulin-like growth factor I to treat hyperglycemic disorder, congestive heart failure, urogenital disorders, poor nutrition, or a wasting syndrome
09/12/2006US7105166 Soluble CTLA4 mutant molecules and uses thereof
09/12/2006US7105165 Mutant human hepatitis B viral strain and uses thereof
09/12/2006US7105163 Mite protein
09/12/2006US7105157 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
09/12/2006CA2347670C Radiolabeled somatostatin-derived peptides for imaging
09/12/2006CA2039021C Dna sequence comprising a structural gene coding for xylose reductase and/or xylitol dehydrogenase
09/08/2006WO2006094161A2 New sources for, and types of, insecticidally active proteins, and polynucleotides that encode the proteins